10.2 C
Friday, December 9, 2022
- Advertisement -


SII’ s second COVID-19 vaccine

Serum Will Test Second COVID-19 Vaccine “Covovax” In The Third Phase From May 15

The Pune-based Serum Institute of India (SII) is likely to start phase III trials of the second COVID-19 vaccine “Covovax”, which it is making in partnership with American company “Novavax”, by May 15.

Latest news

- Advertisement -